CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop computational models to optimize treatment regimens for age-related macular degeneration. By linking drug dosing with imaging techniques, it seeks to personalize therapy and improve patient outcomes in eye care.
With the ageing population, visual threatening illnesses are increasing.
For instance, age-related macular degeneration (AMD) is expected to affect almost 25 million Europeans by 2040.
The AMD treatment consists in regular injections of the anti-VEGF therapeutic drug (Lucentis, Avastin, Eylea) into the eye ball, vitreous, for the rest of the patient life.
However, the dosing intervals varies widely among the patients and there is no a clear consensus or quantitative method for evaluating the inj…
THE UNIVERSITY OF MANCHESTER
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
